Elephas

Elephas is excited to announce that the company is a Bronze sponsor of the annual Badger Challenge! We're honored to support an event that aims to bring the community together in the fight against cancer, with donations directly supporting innovative cancer research, clinical trials, and support programs for cancer patients in Wisconsin. If you want to donate to or join our team, visit our team's fundraising link here: https://xmrrwallet.com/cmx.plnkd.in/eteat_sQ Learn more about the event: https://xmrrwallet.com/cmx.plnkd.in/gMspHKJB #ChangingtheViewofCancer #Innovation #CancerResearch #BadgerChallenge #PoweringResearchCuringCancer

To acknowledge the hard work, expertise, and dedication of our laboratory staff, the Elephas team came together to celebrate Lab Week. This year’s theme was Mission Impossible: “A high-stakes secret mission where teams act as lab agents completing a series of challenges." Throughout the week, we celebrated the importance of lab sciences in a fun, collaborative, and educational way. The team came together to eat, take pictures, and play games that simulated some of the work our laboratory staff does, including a Hydrogel Relay Race and Scavenger Hunt in the lab spaces. A big thank you to our amazing 2025 summer interns for organizing such an exciting mission! #Elephas #ChangingtheViewofCancer #LabSciences #TeamBuilding #LabWeek 

Uncover your immunotherapy’s true potential by identifying likely responders prior to enrollment in your clinical trial. The Elephas Live™ Platform uses live tumor tissue ex vivo to predict response to immunotherapy. If you would like to learn more about our Elephas Live Platform, join us as a partner, or be the first to know updates on our progress, contact us at https://xmrrwallet.com/cmx.plnkd.in/enm8k-vj #Elephas #Immunotherapy #ChangingtheViewofCancer #Pharma #BioPharma #Healthcare #DrugDiscovery #DrugDevelopment #ClinicalTrials #BioTech

Have you seen our latest data that we promoted at the 2025 AACR and ASCO events? At Elephas, we partner with academic institutions to evaluate our ex vivo platform through research collaborations and ongoing clinical trials. Visit our website to learn more about how the Elephas Live platform could transform cancer care: https://xmrrwallet.com/cmx.pelephas.com/data #ASCO2025 #AACR2025 #ClinicalTrials #CancerCare #ChangingtheViewofCancer #Elephas

It's difficult to determine which immunotherapy a cancer patient will respond to since the biological complexity of a live sample is too intricate for traditional approaches to measure. That's why we aim to close the gap in the ability to predict immunotherapy response with an innovative platform. If you want to know what makes Elephas unique, visit our website today. You can also check out some of our recently presented posters at this year's AACR and ASCO events: https://xmrrwallet.com/cmx.pelephas.com/data #ChangingtheViewofCancer #PatientCare #Oncology #Immunotherapy #Cancer #Innovation #CancerResearch

Our team is excited to officially be in Bhubaneswar, Odisha (India), to kick off training for Elephas' collaboration with inDNA Life Sciences Private Limited! We’re partnering in a clinical study that aims to generate evidence showing the Elephas Live Platform can accurately predict response to immunotherapy in an Indian cancer patient population to increase access to these treatments. Stay tuned for more information on this exciting adventure!

Last week, the Elephas team came together for a company onsite where we spent the day connecting, collaborating and enjoying the city of Madison. We're so lucky to have such an amazing team that has the same goal – to create a future where every cancer patient has the opportunity to use our Elephas Live Platform to predict response to immunotherapy. Visit our website to learn more: https://xmrrwallet.com/cmx.plnkd.in/ekEyrc5z #ChangingtheViewofCancer #PatientCare #Oncology #Immunotherapy #Cancer #Innovation #CancerResearch

Elephas is honored that Dr. Mukesh Mahaling, the Minister of Health and Family Welfare of Odisha (India), recently stopped by inDNA Life Sciences Private Limited in Bhubaneswar, Odisha, to learn more about our upcoming partnership! Our collaboration with inDNA is helping identify the predictive capability of our platform to expand access to immunotherapies and ensure that treatments are given to the right patients. The data from the study will allow further validation of the platform and gather critical data for inDNA for future deployment opportunities.

June is Cancer Immunotherapy Month, and we're honored to be a part of a community that supports the general awareness and encourages advancements in the field of cancer immunotherapy. At Elephas, we are passionate about improving the lives of cancer patients with the development of our platform to predict response to immunotherapy. If you're interested in getting involved, check out the Society for Immunotherapy of Cancer (SITC)'s page to learn how to participate in Cancer Immunotherapy Month! https://xmrrwallet.com/cmx.plnkd.in/enNUniT #ChangingtheViewofCancer #Oncology #Immunotherapy #Cancer #ImmunoOncology #CancerImmunotherapy

Today's the day! Hinco J. Gierman, PhD, our Chief Scientific Officer, is currently presenting our #ASCO25 poster titled "Multi-institutional observational prospective clinical trials to assess the accuracy of an ex vivo live tumor fragment platform for predicting immunotherapy response." Stop by Hall A now to learn more and discuss how we may be able to advance your immunotherapy program. You can also visit our website to view the full poster: https://xmrrwallet.com/cmx.pelephas.com/data  #ChangingtheViewofCancer #PatientCare #Oncology #Immunotherapy #Cancer #Innovation #CancerResearch #ImmunoOncology #CancerImmunotherapy American Society of Clinical Oncology (ASCO)